Finance

Lists
Why is 538965 down 3,61%?
Dive Deeper
538965:BOM
Concord Drugs Ltd
69,10 ₹
-3,61%
(-2,59) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 538965...
Open
73,97 ₹
High
73,97 ₹
Low
66,30 ₹
Mkt. cap
910,39 млн
Avg. vol.
4,48 мың
Volume
4,88 мың
P/E ratio
30,84
52-wk high
92,52 ₹
52-wk low
61,00 ₹
EPS
2,24 ₹
Shares outstanding
7,86 млн
No. of employees
250
Open
73,97 ₹
High
73,97 ₹
Low
66,30 ₹
Mkt. cap
910,39 млн
Avg. vol.
4,48 мың
Volume
4,88 мың
P/E ratio
30,84
52-wk high
92,52 ₹
52-wk low
61,00 ₹
EPS
2,24 ₹
Shares outstanding
7,86 млн
No. of employees
250
News stories
From web sources and news partners
About Concord Drugs Ltd
CEO-
Employees250
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
102,76 млн
169,66 млн
378,88 млн
209,39 млн
Cost of goods sold
77,18 млн
143,91 млн
344,01 млн
169,14 млн
Cost of revenue
77,18 млн
143,91 млн
344,01 млн
169,14 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,95 млн
12,37 млн
17,53 млн
12,56 млн
Operating expense
18,01 млн
19,60 млн
23,55 млн
20,92 млн
Total operating expenses
95,19 млн
163,52 млн
367,56 млн
190,06 млн
Operating income
7,57 млн
6,15 млн
11,32 млн
19,33 млн
Other non operating income
26,00 мың
211,00 м.
-1,14 млн
82,00 мың
EBT including unusual items
2,71 млн
2,96 млн
7,48 млн
15,45 млн
EBT excluding unusual items
2,71 млн
2,96 млн
7,48 млн
15,45 млн
Income tax expense
789,00 м.
792,00 м.
2,20 млн
4,31 млн
Effective tax rate
29,08%
26,75%
29,36%
27,89%
Other operating expenses
3,67 млн
4,16 млн
2,50 млн
4,87 млн
Net income
1,92 млн
2,17 млн
5,28 млн
11,14 млн
Net profit margin
1,87%
1,28%
1,39%
5,32%
Earnings per share
-
-
-
-
Interest and investment income
-
-
334,00 м.
-
Interest expense
-4,88 млн
-3,40 млн
-3,04 млн
-3,96 млн
Net interest expenses
-4,88 млн
-3,40 млн
-2,71 млн
-3,96 млн
Depreciation and amortization charges
3,39 млн
3,07 млн
3,53 млн
3,49 млн
EBITDA
11,10 млн
9,72 млн
14,74 млн
22,74 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары